Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
There is a critical need for new therapies for Parkinson’s Disease (PD), a devastating neurodegenerative disease. Current therapies for PD treat disease symptoms, but do not provide a cure. The ability to generate patient brain-derived cells may rapidly advance development of personalized therapies for PD and other incurable neurological disorders. This study will use brain samples from living patients with PD to develop viable human cells specialized to deliver deficient brain chemicals that restore and protect neurological function. The potential clinical benefits of these cells will be tested in animal models of PD. Results of this work support commercialization of new culture products and human brainderived cells for researchers worldwide. This study may further set the foundation for the development of new, innovative, personalized therapies for PD, with potential application in a host of neurological diseases. This work will be performed under partnership with STEMCELL Technologies Inc.
Matthew Hebb
Andrea Di Sebastiano
London Health Sciences Foundation
Medicine
Life sciences
Western University
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.